Page last updated: 2024-08-22

ferric pyrophosphate and Kidney Failure, Chronic

ferric pyrophosphate has been researched along with Kidney Failure, Chronic in 6 studies

*Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. [MeSH]

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Marbury, T; Pratt, RD; van der Horst, E; van Heuveln, F1
Fang, Y; Gan, L; Hui, AM; Li, K; Pratt, R; Tan, Y; Wei, G; Xie, P; Yuan, X; Zhang, L; Zheng, Q; Zhou, Y; Zuo, L1
Chait, Y; Germain, MJ; Nathanson, BH1
Fishbane, S; Shah, HH1
Fishbane, S; Hazzan, AD; Shah, HH1
Amin, NB; Anandan, JV; Besarab, A; Divine, GW; Gupta, A; Vogel, SE; Yee, J1

Reviews

2 review(s) available for ferric pyrophosphate and Kidney Failure, Chronic

ArticleYear
Ferric pyrophosphate citrate as an iron replacement agent for patients receiving hemodialysis.
    Hemodialysis international. International Symposium on Home Hemodialysis, 2017, Volume: 21 Suppl 1

    Topics: Anemia; Clinical Trials as Topic; Diphosphates; Hematinics; Humans; Iron; Kidney Failure, Chronic; Renal Dialysis

2017
Ferric Pyrophosphate Citrate: A Novel Iron Replacement Agent in Patients Undergoing Hemodialysis.
    Seminars in nephrology, 2016, Volume: 36, Issue:2

    Topics: Anemia, Iron-Deficiency; Dialysis Solutions; Diphosphates; Ferric Compounds; Hematinics; Humans; Iron; Kidney Failure, Chronic; Renal Dialysis

2016

Trials

2 trial(s) available for ferric pyrophosphate and Kidney Failure, Chronic

ArticleYear
Pharmacokinetics and Safety of Intravenous Ferric Pyrophosphate Citrate: Equivalence to Administration via Dialysate.
    Journal of clinical pharmacology, 2022, Volume: 62, Issue:5

    Topics: Administration, Intravenous; Citric Acid; Cross-Over Studies; Dialysis Solutions; Diphosphates; Hematinics; Humans; Iron; Kidney Failure, Chronic; Renal Dialysis

2022
Dialysate iron therapy: infusion of soluble ferric pyrophosphate via the dialysate during hemodialysis.
    Kidney international, 1999, Volume: 55, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Dialysis Solutions; Diphosphates; Drug Administration Routes; Erythropoietin; Female; Ferritins; Hemoglobins; Humans; Iron; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Solubility; Transferrin

1999

Other Studies

2 other study(ies) available for ferric pyrophosphate and Kidney Failure, Chronic

ArticleYear
Ethnicity evaluation of ferric pyrophosphate citrate among Asian and Non-Asian populations: a population pharmacokinetics analysis.
    European journal of clinical pharmacology, 2022, Volume: 78, Issue:9

    Topics: Citrates; Dialysis Solutions; Diphosphates; Ethnicity; Hematinics; Humans; Iron; Kidney Failure, Chronic; Reproducibility of Results

2022
Individualized anemia management enhanced by ferric pyrophosphate citrate protocol.
    Scientific reports, 2022, 11-22, Volume: 12, Issue:1

    Topics: Anemia; Citrates; Ferritins; Hematinics; Hemoglobins; Humans; Iron; Kidney Failure, Chronic; Prospective Studies

2022